Reports

93 Results (Page 1 of 4)

Netherlands Markets Research Reports

Pharmaceuticals

Netherlands Cardiovascular Drugs Market Analysis

Netherlands Cardiovascular Drug Market is at around $0.4 Bn in 2022 and is projected to reach $0.5 Bn in 2030, exhibiting a CAGR of 4.3% during the forecast period. Increased elderly population, healthcare accessibility, and healthcare spending & affordability in the country are driving the growth of the market. The market is dominated by key players like Pfizer Inc., Novartis, Sanofi, Merck & Co., Astra Zeneca, Daiichi Sankyo, Takeda Pharmaceutical, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, and Bayer AG.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Medical Devices

Netherlands ECG Equipments Market Analysis

Netherlands's ECG Equipment Market is expected to witness growth from $23 Mn in 2022 to $42 Mn in 2030 with a CAGR of 7.80% for the forecasted year 2022-30. In the Netherlands, there is an increasing focus on preventative healthcare, which is anticipated to increase demand for ECG equipment as consumers take a more proactive approach to monitoring their cardiac health. The market is segmented by product type and by end user. Some key players in this market include Hy2Care B.V., InnoSer, Johnson & Johnson, Philipps Healthcare, Medtronic, GE Healthcare, and Nihon Kohden.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

Netherlands Radiotherapy Market Analysis

By 2030, it is anticipated that the Netherlands Radiotherapy Market will reach a value of $xx Mn from $18 Mn in 2022, growing at a CAGR of xx% during 2022-30. The Radiotherapy Therapeutics Market in the Netherlands is dominated by a few domestic players such as Research Laboratories BV, Philips Healthcare, and Elekta BV. The radiotherapy market in the Netherlands is segmented into different types, technologies, procedures, applications, and end-users. The significant risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Netherlands Radiotherapy is increasing due to the rise in cancer cases in the country.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Healthcare Services

Netherlands Patient Engagement Solutions Market Analysis

Netherlands's patient engagement solutions market is projected to grow from $44.23 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The main factors driving the growth would be a collaborative healthcare system, high adoption of digital technologies, and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality, and by end-user. Some of the major players include Wolter Kluwer, Philips Healthcare, Elsevier, McKesson, and Oracle.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

OTC & Nutraceuticals

Netherlands Over The Counter (OTC) Pharmaceuticals Market Analysis

Netherlands's over-the-counter (OTC) pharmaceuticals market size was valued at $357.5 Mn in 2022 and is estimated to expand at a CAGR of 6.54% from 2022-30 and will reach $593.4 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. The key market players are Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland) and others.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Clinical Trials

Netherlands Oncology Clinical Trials Market Analysis

Netherlands oncology clinical trials Market is projected to grow from $32.9 Mn in 2022 to $52.4 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The market will be driven by the country's strong healthcare system, experienced clinical researchers, and a supportive government. The market is segmented by phase, by study design & by indication. Some of the major players include Roche Holding AG, Pfizer Inc & Kiadis Pharma.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Clinical Trials

Netherlands Neurology Clinical Trials Market Analysis

Netherlands's Neurology Clinical Trials market is projected to grow from $13.6 Mn in 2022 to $21.7 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The market will be driven by the modern healthcare infrastructure and an innovative & collaborative research environment. The market is segmented by phase, by study design & by indication. Some of the major players include Biogen Netherlands BV, Roche Holding AG & Johnson & Johnson.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Clinical Trials

Netherlands Growth Hormone Deficiency Clinical Trials Market Analysis

This report presents a strategic analysis of the Netherlands Growth Hormone Deficiency Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Netherlands Growth Hormone Deficiency Clinical Trials Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Digital Health

Netherlands Digital Therapeutics Market Analysis

This report presents a strategic analysis of the Netherlands Digital Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Netherlands Digital Therapeutics Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Digital Health

Netherlands Digital Health Market Analysis

Netherlands's Digital Health market is projected to grow from $xxBn in 2022 to $xxBn by 2030, registering a CAGR xx% during the forecast period of 2022-30. The market will be driven by the high-quality healthcare services of The Netherlands and the adoption of digitization by the population. The market is segmented by solution, by deployment & by end-use. Some of the major players include Royal Philips, Medtronic & Qompium.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

Netherlands Diabetes Therapeutics Market Analysis

Netherlands's diabetes therapeutics market is expected to witness growth from $374 Mn in 2022 to $814 Mn in 2030 with a CAGR of 10.2% for the forecasted year 2022-30. The rising aging population of the country and the introduction of novel therapeutic options for diabetes in the Netherlands are driving the growth of the market. The Netherlands diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Produlab Pharma, Drogisterij-Parfumerie Visser, and Boehringer Ingelheim are the major players in the Netherlands diabetes therapeutics market.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

Netherlands Diabetes Drugs Market Analysis

This report presents a strategic analysis of the Netherlands Diabetes Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Netherlands Diabetes Drugs Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Medical Devices

Netherlands Coronary Stents Market Analysis

Netherlands's Coronary Stents Market is expected to witness growth from $29 Mn in 2022 to $44 Mn in 2030 with a CAGR of 5.25% for the forecasted year 2022-30. The elderly in the Netherlands are becoming more prevalent, which increases their chance of developing coronary artery disease. The demand for coronary stents and other cardiovascular devices is anticipated to rise as the population continues to age. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include Hy2Care B.V., InnoSer, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare, and Philips Healthcare.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Medical Devices

Netherlands Contraceptive Devices Market Analysis

Netherlands's Contraceptive Devices Market is expected to witness growth from $34 Mn in 2022 to $64 Mn in 2030 with a CAGR of 8.50% for the forecasted year 2022-30. In the Netherlands, as consumers become more aware of the benefits of family planning and contraception, there is an increase in the demand for contraceptive devices. The market is segmented by type and by gender. Some key players in this market include Hy2Care B.V., InnoSer, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

Netherlands Cancer Immunotherapy Market Analysis

Netherlands's cancer immunotherapy market is expected to witness growth from $293 Mn in 2022 to $526 Mn in 2030 with a CAGR of 7.6% for the forecasted year 2022-30. The increased funding in research and development and the creation of novel immunotherapy options are driving the growth of the market. The Netherlands cancer immunotherapy market is segmented by type, application, and end user. Bedrocan, Pharma Line, and Bayer are the major players in the Netherlands' cancer immunotherapy market.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Healthcare Services

Netherlands Bioinformatics Market Analysis

Netherlands's Bioinformatics market is projected to grow from $39.91 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The main factors driving the growth would be strong research and development capabilities, a high level of collaborations and partnerships, and government support. The market is segmented by technology and by application. Some of the major players include Microbial Bioinformatics (NLD), Enpicom (NLD), Crown Bioscience, Illumina, Agilent Technologies, IBM Life Sciences, and Qiagen.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Digital Health

Netherlands Artificial Intelligence (AI) in Diagnostics Market Analysis

Netherlands Artificial Intelligence (AI) in the diagnostics market is projected to grow from $2.6 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The market will be driven by the rising demand for advanced diagnostics and government-led public–private partnership projects. The market is segmented by component & by diagnosis. Some of the major players include Philips Healthcare, IBM Watson Health & Thirona.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

Netherlands ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market Analysis

This report presents a strategic analysis of the Netherlands ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Netherlands ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

Netherlands Oncology Therapeutics Market Analysis

By 2030, it is anticipated that the Netherlands Oncology Therapeutics Market will reach a value of $934 Mn from $472 Mn in 2022, growing at a CAGR of 8.9% during 2022-30. The Oncology Therapeutics Market in the Netherlands is dominated by a few domestic pharmaceutical companies such as Kiadis Pharma, AM-Pharma, and Vico Therapeutics. The Oncology Therapeutics Market in the Netherlands is segmented into different types of cancer and different therapy types. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Netherlands Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Oct, 2023 | PRICE: $3999

Pharmaceuticals

Netherlands Depression Therapeutics Market Analysis

Netherlands' depression therapeutics market is expected to grow from $26 Mn in 2022 to $41 Mn in 2030 with a CAGR of 5.7% for the forecasted year 2022-30. Supportive government policies in the Netherlands related to depression and mental health as well as new and innovative technological advancements in the treatment of depression have led to the development of the market. The Netherlands' depression therapeutics market is segmented by drug type, therapies, indication, and end users. Xenikos, Dannalab, and Pfizer are the major players in the Netherlands' depression therapeutics market.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Oct, 2023 | PRICE: $3999

Clinical Trials

Netherlands Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market Analysis

This report presents a strategic analysis of the Netherlands Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Netherlands' Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Oct, 2023 | PRICE: $3999

Digital Health

Netherlands 3D Imaging Market Analysis

Netherlands's 3D imaging market is projected to grow from $0.08 Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The market will be driven by a solid healthcare infrastructure, a thriving research and development industry, and rising demand for new medical technology. The market is segmented by product, by application, end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers & Pie Medical Imaging.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Oct, 2023 | PRICE: $3999

Medical Devices

Netherlands Medical Devices Market Analysis

This report presents a strategic analysis of the Netherlands Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Netherlands Medical Devices Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jul, 2023 | PRICE: $3999

Healthcare Services

Netherlands Home Healthcare Market Analysis

Netherlands's home healthcare market was valued at $943 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.93% from 2022 to 2030 and will reach $1736 Mn in 2030. One of the main reasons propelling the growth of this market aging population and the rising prevalence of chronic disease. The market is segmented by equipment and service. Some key players in this market are Molnlycke Health Care, ConvaTec Group plc, Melsungen AG, Hollister, Coloplast, Medline Industries, and Acelity among others.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jun, 2023 | PRICE: $3999

Digital Health

Netherlands Artificial Intelligence (AI) in Healthcare Market Analysis

Netherlands's Artificial Intelligence (AI) In healthcare market is projected to grow from $0.02 Bn in 2022 to $0.36 Bn by 2030, registering a CAGR of 45.72% during the forecast period of 2022 - 2030. The market will be driven by the country’s strong healthcare system, a culture of innovation and collaboration, and government assistance for research and development. The market is segmented by healthcare components & by healthcare applications. Some of the major players include Philips Healthcare, Aidence & Quantib.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jun, 2023 | PRICE: $3999

subscribe to our newsletter
up